Ropinirole Extended Release Oral Tablet
RxNorm 799053
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 799053 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: ropinirole Extended Release Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDFPrescribable
Semantic Clinical Drug Form (SCDF):
Ropinirole Extended Release Oral Tablet
(Atom ID: 6350311)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
ROPINIRole Extended Release Oral Tablet
(Atom ID: 6376274)
Patient Education
Ropinirole
Ropinirole is used alone or with other medications to treat the symptoms of Parkinson's disease (PD; a disorder of the nervous system that causes difficulties with movement, muscle control, and balance), including shaking of parts of the body, stiffness, slowed movements, and problems with balance. Ropinirole is also used to treat restless legs syndrome (RLS or Ekbom syndrome; a condition that causes discomfort in the legs and a strong urge to move the legs, especially at night and when sitting or lying down). Ropinirole is in a class of medications called dopamine agonists. It works by acting in place of dopamine, a natural substance in the brain that is needed to control movement.
[Learn More]
* Please review the disclaimer below.